Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.8850 (0.73%) ($6.6300 - $6.9900) on Fri. Jul. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.97% (three month average) | RSI | 11 | Latest Price | $6.8850(0.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.3% a day on average for past five trading days. | Weekly Trend | CGEN declines -7.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(72%) ARKG(70%) ARKK(67%) IWO(66%) ACES(63%) | Factors Impacting CGEN price | CGEN will decline at least -1.985% in a week (0% probabilities). VIXM(-49%) VXX(-37%) UUP(-15%) TLT(-8%) SHY(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.985% (StdDev 3.97%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.39(-178.29%) | Resistance Level | $7.79 | 5 Day Moving Average | $7.17(-3.97%) | 10 Day Moving Average | $7.42(-7.21%) | 20 Day Moving Average | $7.79(-11.62%) | To recent high | -24.2% | To recent low | 0.7% | Market Cap | $569m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |